期刊文献+

洛伐他汀减轻NMDA诱导的兴奋性毒性损害

Lovastatin attenuates NMDA induced excitotoxicity in rat cortical neurons
下载PDF
导出
摘要 目的探讨洛伐他汀(Lovastatin,LOV)对NMDA诱导的大鼠皮质神经元兴奋性毒性损害的神经保护作用。方法选用胚胎17d的SD大鼠,取皮质神经元接种培养。通过台盼蓝排除实验评估细胞活力、TUNEL染色检测凋亡细胞及免疫荧光细胞化学技术测定神经元形态。结果台盼蓝排除实验显示500nmol/L洛伐他汀预处理3d显著减轻NMDA诱导的大鼠皮质神经元兴奋性毒性损害,而不能减少蛋白激酶C抑制剂星形孢菌素诱导的细胞凋亡。LOV和L-甲羟戊酸(MVA)共同预处理不能减轻NMDA诱导的兴奋性毒性损害,提示其保护作用依赖于降低胆固醇水平。洛伐他汀的神经保护作用呈剂量和时程依赖性。TUNEL染色显示洛伐他汀预处理能减少NMDA诱导的细胞凋亡。免疫荧光细胞化学结果显示洛伐他汀能改善NMDA诱导的MAP-2神经元形态损害。结论洛伐他汀选择性地减轻NMDA诱导的大鼠皮质神经元兴奋性毒性损害及形态损害,提示洛伐他汀对兴奋性毒性损害相关神经病理有潜在的神经保护作用。 Objective To observe the effect of lovastatin on NMDA induced excitotoxicity in rat cortical neurons.Methods Cortical neurons were prepared from E17 rat.Cell viability was evaluated with typan blue dye exclusion test,apoptosis was detected with TUNEL staining,and the morphology and number of neurons was assessed with MAP-2 immunofluorescence staining.Results Typan blue staining demonstrated that 500 nmol/L lovastatin pre-treatment 3d significantly and selectively protected neurons against NMDA induced excitotoxicity but not against staurosporine induced apoptosis.The protective effects were completely abolished co-treated with lovastatin and MVA,indicating protection was dependent on cholesterol-lowering.Moreover,protection of lovastatin was dosage-and time-dependent.In line with this evidence,lovastatin decreased apoptosis upon NMDA by TUNEL staining.Immunofluorescence staining demonstrated the number of MAP-2 positive neurons decreased and survival neurons showed a loss of MAP-2 positive dendrites after NMDA treatment,which were not visible after lovastatin pre-treatment.Conclusions Lovastatin significantly and selectively attenuated NMDA induced excitotoxicity,indicating that lovastatin has potential neuroprotective effects on excitotoxicity-related neuropathology.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2011年第6期520-523,共4页 Journal of Apoplexy and Nervous Diseases
基金 国家自然科学基金资助项目(81000561)
关键词 洛伐他汀 NMDA 星形孢菌素 神经保护 大鼠 Lovastatin NMDA Staurosporine Neuroprotection Rat
  • 相关文献

参考文献14

  • 1Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvasta- tin after stroke or transient ischemic attack[J]. N Engl J Med,2006, 355(6) :549 -559.
  • 2秦玲,张淑琴,张家颖.阿托伐他汀对家兔动脉粥样硬化血管细胞粘附分子-1基因表达的影响[J].中风与神经疾病杂志,2005,22(4):300-302. 被引量:5
  • 3Ye Y, Perez-Polo JR, Bimbaum Y. Protecting against ischemia-reper- fusion injury : antiplatelet drugs, statins, and their potential interac- tions[ J]. Ann N Y Acad Sci ,2010,1207:76 - 82.
  • 4Aarts MM, Arundine M, Tymianski M. Novel concepts in excitotoxic neurodegeneration after stroke [ J ]. Expert Rev Mol Med, 2003,5 (30) :1 -22.
  • 5Xu J, Zhang QG, Li C, et aL Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation [ J ]. Hippocam- pus,2007,17(7) :525 -537.
  • 6马涛,凌树才,倪衡建.一氧化氮对体外培养的胚鼠脑干5-羟色胺能神经元生长发育的影响[J].神经解剖学杂志,2006,22(3):323-327. 被引量:4
  • 7Stout AK, Raphael HM, Kanterewicz BI, et al. Glutamate-induced neuron death requires mitochondfial calcium uptake[ J]. Nat Neuros- ci, 1998,1 (5) :366 - 373.
  • 8Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdraw- al in ischemic stroke:a controlled randomized study [ J]. Neurology, 2007,69 (9) :904 - 910.
  • 9Milionis H J, Giannopoulos S, Kosmidou M, et al. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival [J]. Neurology,2009,72(21) :1816 - 1822.
  • 10Lira JH, Lee JC, Lee YH, et al. Simvastatin prevents oxygen and glu- cose deprivation/reoxygenation-induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal[ J ]. J Neurochem ,2006,97 ( 1 ) : 140 - 150.

二级参考文献21

  • 1冯宗忱.动脉粥样硬化——血管壁的慢性炎症[J].中华心血管病杂志,2005,33(5):393-394. 被引量:66
  • 2LiH,Cybulsky MI,Gimbrone MA Jr,et al. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma [J]. Pathol, 1993,143: 1551-1559.
  • 3Anne Hackman,Yasunori Abe. Levels of soluble adhesion in patients with dyslipidemia circulation[J]. 1996,93:1334-1338.
  • 4Cannon CP,Braunwald E,McCabe CH,et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators, intensive versus moderate lipid lowering with statin after acute coronary syndromes[J]. N Engl J Med, 2004,350 : 1495-1504.
  • 5Fang L,Wei H,Mak KH,et al. Marker of low-grade inflammation and soluble cell adhension molecules in Chinese patients with coronary artery disease[J]. Cardiol,2004,20(14) :1433-1438.
  • 6Funatsn T,Kakuta H ,Tanaka H,et al. Atorvastatin(lipitor);a review of its pharmacological and clinical profile[J]. Nippon Yakurigaku Zasshi, 2001,117 ( 1 ): 65-69.
  • 7Whitaker-Azmitia PM,Druse M,Walker P et al.Serotonin as a developmental signal.Behav Brain Res,1996 ;73:19-29
  • 8Leger L,Charnay Y,Burlet S et al.Comparative distribution of nitric oxide synthase-and serotonin-containing neurons in the raphe nuclei of four mammalian species.Histochem Cell Biol,1998;110:517 -525
  • 9Gally JA,Montague PR,Reeke GN Jr et al.The NO hypothesis:possible effects of a short-lived,rapidly diffusible signal in the development and function of the nervous system.Proc Natl Acad Sci USA,1990 ;87:3547-3551
  • 10Moritz GC,Tenorio F,Allodi S et al.Expression of nitric oxide synthase in the developing rat hippocampus.Neurosci Lett,1999;263:89-92

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部